249 related articles for article (PubMed ID: 7729909)
1. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae.
Berry AM; Alexander JE; Mitchell TJ; Andrew PW; Hansman D; Paton JC
Infect Immun; 1995 May; 63(5):1969-74. PubMed ID: 7729909
[TBL] [Abstract][Full Text] [Related]
2. Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene.
Berry AM; Ogunniyi AD; Miller DC; Paton JC
Infect Immun; 1999 Feb; 67(2):981-5. PubMed ID: 9916120
[TBL] [Abstract][Full Text] [Related]
3. The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model.
Benton KA; Paton JC; Briles DE
Microb Pathog; 1997 Oct; 23(4):201-9. PubMed ID: 9344781
[TBL] [Abstract][Full Text] [Related]
4. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.
Berry AM; Yother J; Briles DE; Hansman D; Paton JC
Infect Immun; 1989 Jul; 57(7):2037-42. PubMed ID: 2731982
[TBL] [Abstract][Full Text] [Related]
5. Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3.
Berry AM; Paton JC; Hansman D
Microb Pathog; 1992 Feb; 12(2):87-93. PubMed ID: 1350046
[TBL] [Abstract][Full Text] [Related]
6. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins.
Berry AM; Paton JC
Infect Immun; 2000 Jan; 68(1):133-40. PubMed ID: 10603379
[TBL] [Abstract][Full Text] [Related]
7. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.
Alexander JE; Berry AM; Paton JC; Rubins JB; Andrew PW; Mitchell TJ
Microb Pathog; 1998 Mar; 24(3):167-74. PubMed ID: 9514638
[TBL] [Abstract][Full Text] [Related]
8. The role of pneumolysin in ocular infections with Streptococcus pneumoniae.
Johnson MK; Hobden JA; Hagenah M; O'Callaghan RJ; Hill JM; Chen S
Curr Eye Res; 1990 Nov; 9(11):1107-14. PubMed ID: 2095322
[TBL] [Abstract][Full Text] [Related]
9. Differences in virulence of pneumolysin and autolysin mutants constructed by insertion duplication mutagenesis and in-frame deletion in Streptococcus pneumoniae.
Liu EY; Chang FY; Chang JC; Fung CP
BMC Biotechnol; 2014 Feb; 14():16. PubMed ID: 24558977
[TBL] [Abstract][Full Text] [Related]
10. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.
Ogunniyi AD; LeMessurier KS; Graham RM; Watt JM; Briles DE; Stroeher UH; Paton JC
Infect Immun; 2007 Apr; 75(4):1843-51. PubMed ID: 17261599
[TBL] [Abstract][Full Text] [Related]
11. Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood.
Harvey RM; Ogunniyi AD; Chen AY; Paton JC
Infect Immun; 2011 Oct; 79(10):4122-30. PubMed ID: 21788389
[TBL] [Abstract][Full Text] [Related]
12. Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae.
Johnson MK; Hobden JA; O'Callaghan RJ; Hill JM
Curr Eye Res; 1992 Dec; 11(12):1221-5. PubMed ID: 1490340
[TBL] [Abstract][Full Text] [Related]
13. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
[TBL] [Abstract][Full Text] [Related]
14. Biological properties of pneumolysin.
Mitchell TJ; Andrew PW
Microb Drug Resist; 1997; 3(1):19-26. PubMed ID: 9109093
[TBL] [Abstract][Full Text] [Related]
15. Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea.
Johnson MK; Callegan MC; Engel LS; O'Callaghan RJ; Hill JM; Hobden JA; Boulnois GJ; Andrew PW; Mitchell TJ
Curr Eye Res; 1995 Apr; 14(4):281-4. PubMed ID: 7606914
[TBL] [Abstract][Full Text] [Related]
16. Expression of the pneumolysin gene in Escherichia coli: rapid purification and biological properties.
Mitchell TJ; Walker JA; Saunders FK; Andrew PW; Boulnois GJ
Biochim Biophys Acta; 1989 Jan; 1007(1):67-72. PubMed ID: 2642385
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci.
Dessing MC; Florquin S; Paton JC; van der Poll T
Cell Microbiol; 2008 Jan; 10(1):237-46. PubMed ID: 17711480
[TBL] [Abstract][Full Text] [Related]
18. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms.
Shak JR; Ludewick HP; Howery KE; Sakai F; Yi H; Harvey RM; Paton JC; Klugman KP; Vidal JE
mBio; 2013 Sep; 4(5):e00655-13. PubMed ID: 24023386
[TBL] [Abstract][Full Text] [Related]
19. Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production.
Benton KA; Paton JC; Briles DE
Infect Immun; 1997 Apr; 65(4):1237-44. PubMed ID: 9119457
[TBL] [Abstract][Full Text] [Related]
20. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae.
Rossjohn J; Gilbert RJ; Crane D; Morgan PJ; Mitchell TJ; Rowe AJ; Andrew PW; Paton JC; Tweten RK; Parker MW
J Mol Biol; 1998 Nov; 284(2):449-61. PubMed ID: 9813129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
